End Fund Inc is a 501(c)(3) organization based in New York, New York, registered in 2011, with $62,672,882 in FY2024 revenue. CharityIndex grades it B+, and it directs about 90% of spending to programs.
Revenue (FY2024)
$62.7M
▲ 11.1% vs prior year
International median: $227K
Expenses (FY2024)
$74.2M
Net assets
$36.1M
Employees
44
Rated on 4 of 4 criteria.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For End Fund Inc: 90% to programs · $8 to raise $100 earns a A+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For End Fund Inc: 6 mo reserves · -18% margin earns a C+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For End Fund Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For End Fund Inc: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
The end fund's mission is to control and eliminate six neglected tropical diseases: river blindness, lymphatic filariasis, trachoma, schistosomiasis, intestinal worms, and visceral leishmaniasis.
Revenue grew from $26.7M (FY2014) to $62.7M (FY2024) across 10 reported years.
Financial snapshot
Operating margin
-18.4%
Spent more than it raised in the latest fiscal year.
Total assets
$38.9M
Total liabilities
$2.8M
Net assets
$36.1M
Salaries & benefits
$13.0M
18% of expenses
Board members
6
6 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $62,672,882▲11.1% | $74,181,557▲15.8% | $36,143,779▼24.3% | $38,929,869▼22.8% | 990 |
| 2023 | $56,392,358▼28.7% | $64,042,913▲5.9% | $47,718,943▼14.5% | $50,403,877▼14.0% | 990 |
| 2022 | $79,135,799▲126% | $60,493,617▲63.6% | $55,807,154▲50.0% | $58,581,667▲56.3% | 990 |
| 2021 | $35,034,243▲53.7% | $36,973,338▲28.1% | $37,194,580▼5.0% | $37,486,570▼4.9% | 990 |
| 2020 | $22,787,083▼49.3% | $28,854,476▼7.0% | $39,133,675▼13.4% | $39,399,933▼13.2% | 990 |
| 2019 | $44,978,754▲135% | $31,011,608▲82.2% | $45,201,068▲55.1% | $45,414,106▲55.2% | 990 |
| 2017 | $19,141,440▲8.4% | $17,017,684▲5.6% | $29,143,069▲7.9% | $29,256,045▲8.1% | 990 |
| 2016 | $17,665,991▲63.6% | $16,109,756▲19.7% | $27,019,313▲6.1% | $27,069,526▲6.0% | 990 |
| 2015 | $10,799,719▼59.6% | $13,456,665▲86.9% | $25,463,078▼9.4% | $25,546,849▼9.4% | 990 |
| 2014 | $26,704,014 | $7,200,615▲52.7% | $28,120,024▲861% | $28,196,472▲855% | 990 |
| 2012 | — | $4,714,119 | $2,925,989 | $2,952,072 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Diana Benton Schechter — $394,601 (0.53% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Diana Benton Schechter | Coo / Board Secretary (thru June 15, 2024) Interim Ceo (as of June 15, 2024) | 40 | $394,601 |
| Daniel Daley | Sr Vp of Finance and Admin (thru June 15, 2024), Acting Coo (as of June 15, 2024) | 40 | $373,799 |
| Ellen Agler | Ceo Thru June 15, 2024 | 40 | $284,219 |
| Samuel Mayer | Vp of Global Strategic Partnerships | 40 | $267,765 |
| Caroline Karutu | Vp of Programs | 40 | $259,477 |
| Mireille Mather | Vp of Investor Relations | 40 | $245,865 |
| Ellie Dehghan | Head of Legal & Global Operations | 40 | $233,865 |
| Modupeola Odusote | Head of Culture & Talent | 40 | $227,398 |
| Alan Mccormick | Vice Chair | 1 | — |
| Christine Wachter Campbell | Director | 1 | — |
| English Sall | Director | 1 | — |
| Michael Hoffman | Director | 1 | — |
| Moses Bockarie | Director | 1 | — |
| Scott Powell | Treasurer (thru December 1, 2024) | 1 | — |
| Tsitsi Masiyiwa | Chair | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Atlas Technology Solutions Inc | Global Employer of Record | $6,306,751 |
| Elevate Destinations | Travel, Event Meeting Service | $418,619 |
| Davycas International | Consulting | $338,067 |
| Wi-her LLC | Consulting | $255,548 |
| Panorama Strategy | Consulting | $254,700 |
58 grants to End Fund Inc totaling $43.0M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| American Online Giving Foundation Inc | General support | 2024 | $8,434 |
| Raymond James Charitable Endowment Fund | General support | 2024 | $5,700 |
| National Philanthropic Tr | Public, societal benefit | 2023 | $9,779,005 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $1,277,645 |
| Gates Philanthropy Partners | Neglected tropical diseases | 2023 | $500,000 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2023 | $44,000 |
| American Online Giving Foundation Inc | General support | 2023 | $15,788 |
| Donor Advised Charitable Giving | International, foreign affairs | 2023 | $9,100 |
| Raymond James Charitable Endowment Fund | General support | 2023 | $8,000 |
| National Philanthropic Tr | International | 2022 | $10,366,900 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2022 | $1,337,141 |
| The Clear Fund | Deworming program | 2022 | $61,085 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2022 | $41,536 |
| Effective Ventures Foundation USA | General nonprofit support | 2022 | $26,144 |
| Donor Advised Charitable Giving | International, foreign affairs | 2022 | $23,300 |
6 grants totaling $9.5M in FY2024. All grants made by End Fund Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| The Carter Center Inc | Ntds | $3,173,117 |
| United Front Against River Blindness | Ntds | $2,345,882 |
| Project Orbis International Inc | Ntds | $2,182,879 |
| Helen Keller International | Ntds | $885,410 |
| Interchurch Medical Assistance Inc | Ntds | $787,500 |
| Akros Inc | Ntds | $138,695 |
Explore more
Data for End Fund Inc (EIN 27-3941186) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.